# James River Group Holdings, Inc.: financial statements, quarterly

JRVR · Nasdaq · CIK 1620459 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jrvr.md) · [Financials](/companies/jrvr/financials.md) · [Filings](/companies/jrvr/filings.md) · [Insiders](/companies/jrvr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jrvr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [210](/filings/0001620459-24-000123.md) | [218](/filings/0001620459-24-000022.md) | [201](/filings/0001620459-25-000072.md) | [188](/filings/0001620459-25-000108.md) | [191](/filings/0001620459-25-000134.md) | [127 d](/filings/0001620459-26-000009.md) | [172](/filings/0001620459-26-000028.md) | [175](/filings/0001620459-26-000045.md) | [173](/filings/0001620459-25-000134.md) | [168 d](/filings/0001620459-26-000009.md) | [151](/filings/0001620459-26-000028.md) | [161](/filings/0001620459-26-000045.md) |
| Interest expense | $m | [6.5](/filings/0001620459-24-000123.md) | [6.6 d](/filings/0001620459-26-000009.md) | [6.5](/filings/0001620459-25-000072.md) | [6.3](/filings/0001620459-25-000108.md) | [6.1](/filings/0001620459-25-000134.md) | [5.7 d](/filings/0001620459-26-000009.md) | [5.5](/filings/0001620459-26-000028.md) | [5.8](/filings/0001620459-26-000045.md) | [6.2](/filings/0001620459-25-000134.md) | [6.0 d](/filings/0001620459-26-000009.md) | [5.6](/filings/0001620459-26-000028.md) | [5.6](/filings/0001620459-26-000045.md) |
| Income tax | $m | [7.0](/filings/0001620459-24-000123.md) | [10.2 d](/filings/0001620459-26-000009.md) | [9.5](/filings/0001620459-25-000072.md) | [5.7](/filings/0001620459-25-000108.md) | [(13.9)](/filings/0001620459-25-000134.md) | [(8.9) d](/filings/0001620459-26-000009.md) | [5.0](/filings/0001620459-26-000028.md) | [2.2](/filings/0001620459-26-000045.md) | [1.1](/filings/0001620459-25-000134.md) | [(7.6) d](/filings/0001620459-26-000009.md) | [(1.9)](/filings/0001620459-26-000028.md) | [1.8](/filings/0001620459-26-000045.md) |
| Net income | $m | [19.6](/filings/0001620459-24-000123.md) | [(150)](/filings/0001620459-24-000022.md) | [15.4](/filings/0001620459-25-000072.md) | [7.6](/filings/0001620459-25-000108.md) | [(39.4)](/filings/0001620459-25-000134.md) | [(64.8) d](/filings/0001620459-26-000009.md) | [9.6](/filings/0001620459-26-000028.md) | [4.8](/filings/0001620459-26-000045.md) | [1.0](/filings/0001620459-25-000134.md) | [32.1 d](/filings/0001620459-26-000009.md) | [(8.9)](/filings/0001620459-26-000028.md) | [6.4](/filings/0001620459-26-000045.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001620459-24-000123.md) | [(3.43)](/filings/0001620459-24-000022.md) | [0.35](/filings/0001620459-25-000072.md) | [0.13](/filings/0001620459-25-000108.md) | [(1.10)](/filings/0001620459-25-000134.md) | not reported | [0.16](/filings/0001620459-26-000028.md) | [0.06](/filings/0001620459-26-000045.md) | [(0.02)](/filings/0001620459-25-000134.md) | not reported | [(0.23)](/filings/0001620459-26-000028.md) | [0.10](/filings/0001620459-26-000045.md) |
| Basic EPS | $ per share | [0.45](/filings/0001620459-24-000123.md) | [(4.06)](/filings/0001620459-24-000022.md) | [0.34](/filings/0001620459-25-000072.md) | [0.13](/filings/0001620459-25-000108.md) | [(1.10)](/filings/0001620459-25-000134.md) | not reported | [0.17](/filings/0001620459-26-000028.md) | [0.06](/filings/0001620459-26-000045.md) | [(0.02)](/filings/0001620459-25-000134.md) | not reported | [(0.23)](/filings/0001620459-26-000028.md) | [0.10](/filings/0001620459-26-000045.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [233](/filings/0001620459-23-000138.md) | [274](/filings/0001620459-25-000010.md) | [305](/filings/0001620459-24-000089.md) | [673](/filings/0001620459-24-000109.md) | [360](/filings/0001620459-24-000123.md) | [362](/filings/0001620459-26-000009.md) | [279](/filings/0001620459-25-000072.md) | [220](/filings/0001620459-25-000108.md) | [239](/filings/0001620459-25-000134.md) | [261](/filings/0001620459-26-000045.md) | [228](/filings/0001620459-26-000028.md) | [196](/filings/0001620459-26-000045.md) |
| Total assets | $m | [5,193](/filings/0001620459-23-000138.md) | [5,317](/filings/0001620459-25-000010.md) | [5,251](/filings/0001620459-24-000089.md) | [4,738](/filings/0001620459-25-000108.md) | [4,959](/filings/0001620459-25-000134.md) | [5,007](/filings/0001620459-26-000009.md) | [4,949](/filings/0001620459-25-000072.md) | [5,018](/filings/0001620459-25-000108.md) | [4,950](/filings/0001620459-25-000134.md) | [4,860](/filings/0001620459-26-000045.md) | [4,762](/filings/0001620459-26-000028.md) | [4,773](/filings/0001620459-26-000045.md) |
| Total liabilities | $m | [4,486](/filings/0001620459-23-000138.md) | [4,638](/filings/0001620459-25-000010.md) | [4,566](/filings/0001620459-24-000089.md) | [4,052](/filings/0001620459-24-000109.md) | [4,283](/filings/0001620459-24-000123.md) | [4,413](/filings/0001620459-26-000009.md) | [4,331](/filings/0001620459-25-000072.md) | [4,393](/filings/0001620459-25-000108.md) | [4,314](/filings/0001620459-25-000134.md) | [4,189](/filings/0001620459-26-000045.md) | [4,110](/filings/0001620459-26-000028.md) | [4,117](/filings/0001620459-26-000045.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [563](/filings/0001620459-24-000123.md) | [535](/filings/0001620459-26-000009.md) | [540](/filings/0001620459-25-000108.md) | [542](/filings/0001620459-25-000134.md) | [530](/filings/0001620459-25-000134.md) | [461](/filings/0001620459-26-000045.md) | [484](/filings/0001620459-26-000045.md) | [493](/filings/0001620459-26-000045.md) | [504](/filings/0001620459-25-000134.md) | [538](/filings/0001620459-26-000045.md) | [518](/filings/0001620459-26-000045.md) | [523](/filings/0001620459-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [55.1 d](/filings/0001620459-24-000123.md) | [(9.8) d](/filings/0001620459-26-000009.md) | [24.1](/filings/0001620459-25-000072.md) | [(8.7) d](/filings/0001620459-25-000108.md) | [(270) d](/filings/0001620459-25-000134.md) | [7.5 d](/filings/0001620459-26-000009.md) | [(51.5)](/filings/0001620459-26-000028.md) | [25.2 d](/filings/0001620459-26-000045.md) | [34.3 d](/filings/0001620459-25-000134.md) | [(26.8) d](/filings/0001620459-26-000009.md) | [(0.7)](/filings/0001620459-26-000028.md) | [(5.1) d](/filings/0001620459-26-000045.md) |
| Capital expenditure | $m | [1.1 d](/filings/0001620459-24-000123.md) | [3.1 d](/filings/0001620459-26-000009.md) | [0.7](/filings/0001620459-25-000072.md) | [0.6 d](/filings/0001620459-25-000108.md) | [0.8 d](/filings/0001620459-25-000134.md) | [2.7 d](/filings/0001620459-26-000009.md) | [1.2](/filings/0001620459-26-000028.md) | [0.5 d](/filings/0001620459-26-000045.md) | [0.7 d](/filings/0001620459-25-000134.md) | [2.5 d](/filings/0001620459-26-000009.md) | [0.1](/filings/0001620459-26-000028.md) | [0.9 d](/filings/0001620459-26-000045.md) |
| Dividends paid | $m | [1.9 d](/filings/0001620459-24-000123.md) | [1.9 d](/filings/0001620459-26-000009.md) | [2.0](/filings/0001620459-25-000072.md) | [1.9 d](/filings/0001620459-25-000108.md) | [1.9 d](/filings/0001620459-25-000134.md) | [0.4 d](/filings/0001620459-26-000009.md) | [0.6](/filings/0001620459-26-000028.md) | [0.5 d](/filings/0001620459-26-000045.md) | [0.5 d](/filings/0001620459-25-000134.md) | [0.5 d](/filings/0001620459-26-000009.md) | [0.5](/filings/0001620459-26-000028.md) | [0.5 d](/filings/0001620459-26-000045.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.5](/filings/0001620459-23-000138.md) | [37.8](/filings/0001620459-24-000089.md) | [37.9](/filings/0001620459-24-000109.md) | [43.5](/filings/0001620459-24-000123.md) | [44.6](/filings/0001620459-25-000072.md) | [38.0](/filings/0001620459-25-000108.md) | [37.9](/filings/0001620459-25-000134.md) | [59.7](/filings/0001620459-26-000028.md) | [46.7](/filings/0001620459-26-000045.md) | [46.0](/filings/0001620459-25-000134.md) | [46.1](/filings/0001620459-26-000028.md) | [47.0](/filings/0001620459-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,239,030 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001620459-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.